Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Non Operating Income: 2012-2024

Historic Non Operating Income for Ani Pharmaceuticals (ANIP) over the last 13 years, with Dec 2024 value amounting to -$4.0 million.

  • Ani Pharmaceuticals' Non Operating Income rose 66.35% to -$853,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$294,000, marking a year-over-year increase of 89.06%. This contributed to the annual value of -$4.0 million for FY2024, which is 2436.48% down from last year.
  • Latest data reveals that Ani Pharmaceuticals reported Non Operating Income of -$4.0 million as of FY2024, which was down 2,436.48% from -$159,000 recorded in FY2023.
  • In the past 5 years, Ani Pharmaceuticals' Non Operating Income ranged from a high of $670,000 in FY2022 and a low of -$4.3 million during FY2021.
  • For the 3-year period, Ani Pharmaceuticals' Non Operating Income averaged around -$1.2 million, with its median value being -$159,000 (2023).
  • In the last 5 years, Ani Pharmaceuticals' Non Operating Income skyrocketed by 115.43% in 2022 and then tumbled by 2,436.48% in 2024.
  • Ani Pharmaceuticals' Non Operating Income (Yearly) stood at -$494,000 in 2020, then crashed by 779.15% to -$4.3 million in 2021, then spiked by 115.43% to $670,000 in 2022, then tumbled by 123.73% to -$159,000 in 2023, then slumped by 2,436.48% to -$4.0 million in 2024.